Subject to regulatory approvals, the new company intends to launch its first product with StrandDx™- ASD a molecular biomarker for autism spectrum disorder that can be applied at birth, and can assist in early Autism Spectrum Disorder diagnosis.
Rescue and recovery workers who attended the World Trade Center site are beginning to develop chronic obstructive pulmonary disease (COPD), according to research presented at the European Respiratory Society International Congress by Mount Sinai researchers.
A new peer-reviewed study in Nature Communications shows how pre-existing neighborhood social factors like housing, work, income, insurance help explain the higher rates of infection for COVID19 in communities of color.
Researchers from the Mount Sinai Institute for Exposomic Research are first to find ultrafine particles from traffic pollution influences asthma risk in U.S. children
Mount Sinai Research Could Result in Early Diagnostic System for Autism Spectrum Disorder
